These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26890225)

  • 1. Assessment of Chromosomal DNA Fragmentation by Quinolones in an Isogenic Collection of Escherichia coli with Defined Resistance Mechanisms.
    Rodríguez-Martínez JM; Santiso R; Machuca J; Bou G; Pascual Á; Fernández JL
    Microb Drug Resist; 2016 Jul; 22(5):354-9. PubMed ID: 26890225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary Tract Physiological Conditions Promote Ciprofloxacin Resistance in Low-Level-Quinolone-Resistant Escherichia coli.
    Martín-Gutiérrez G; Rodríguez-Beltrán J; Rodríguez-Martínez JM; Costas C; Aznar J; Pascual Á; Blázquez J
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4252-8. PubMed ID: 27139482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark.
    Cavaco LM; Frimodt-Møller N; Hasman H; Guardabassi L; Nielsen L; Aarestrup FM
    Microb Drug Resist; 2008 Jun; 14(2):163-9. PubMed ID: 18500921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of AAC(6')-Ib-cr in combination with chromosomal-mediated mechanisms on clinical quinolone resistance in Escherichia coli.
    Machuca J; Ortiz M; Recacha E; Díaz-De-Alba P; Docobo-Perez F; Rodríguez-Martínez JM; Pascual Á
    J Antimicrob Chemother; 2016 Nov; 71(11):3066-3071. PubMed ID: 27494906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid and simple determination of ciprofloxacin resistance in clinical strains of Escherichia coli.
    Santiso R; Tamayo M; Fernández JL; del Carmen Fernández M; Molina F; Villanueva R; Gosálvez J; Bou G
    J Clin Microbiol; 2009 Aug; 47(8):2593-5. PubMed ID: 19571026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinolone Resistance Reversion by Targeting the SOS Response.
    Recacha E; Machuca J; Díaz de Alba P; Ramos-Güelfo M; Docobo-Pérez F; Rodriguez-Beltrán J; Blázquez J; Pascual A; Rodríguez-Martínez JM
    mBio; 2017 Oct; 8(5):. PubMed ID: 29018116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of plasmid-mediated quinolone resistance determinants among Escherichia coli isolated from food animals in Korea.
    Tamang MD; Nam HM; Chae MH; Kim SR; Gurung M; Jang GC; Jung SC; Lim SK
    Foodborne Pathog Dis; 2012 Dec; 9(12):1057-63. PubMed ID: 23186547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of the SOS response modifies spatiotemporal evolution, post-antibiotic effect, bacterial fitness and biofilm formation in quinolone-resistant Escherichia coli.
    Recacha E; Machuca J; Díaz-Díaz S; García-Duque A; Ramos-Guelfo M; Docobo-Pérez F; Blázquez J; Pascual A; Rodríguez-Martínez JM
    J Antimicrob Chemother; 2019 Jan; 74(1):66-73. PubMed ID: 30329046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of clinical categories for Escherichia coli harboring specific qnr and chromosomal-mediated fluoroquinolone resistance determinants according to CLSI and EUCAST.
    Machuca J; Briales A; Díaz-de-Alba P; Martínez-Martínez L; Rodríguez-Martínez JM; Pascual Á
    Enferm Infecc Microbiol Clin; 2016 Mar; 34(3):188-90. PubMed ID: 25772329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mutations of gyrA in ciprofloxacin resistant Escherichia coli strains].
    Eraç B; Gill A; Amyes SG; Gülay Z
    Mikrobiyol Bul; 2003; 37(2-3):125-30. PubMed ID: 14593893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of fluoroquinolones and fluoroquinolone-resistance genes in the aquatic environment.
    Adachi F; Yamamoto A; Takakura K; Kawahara R
    Sci Total Environ; 2013 Feb; 444():508-14. PubMed ID: 23291652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High rates of plasmid-mediated quinolone resistance QnrB variants among ciprofloxacin-resistant Escherichia coli and Klebsiella pneumoniae from urinary tract infections in Korea.
    Shin JH; Jung HJ; Lee JY; Kim HR; Lee JN; Chang CL
    Microb Drug Resist; 2008 Sep; 14(3):221-6. PubMed ID: 18707554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of QnrA, a Plasmid-Mediated Quinolone Resistance Peptide, to Survival of Escherichia coli Exposed to a Lethal Ciprofloxacin Concentration.
    Goto K; Kawamura K; Arakawa Y
    Jpn J Infect Dis; 2015; 68(3):196-202. PubMed ID: 25672356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of low-level quinolone resistance in generating tolerance in Escherichia coli under therapeutic concentrations of ciprofloxacin.
    Ortiz-Padilla M; Diaz-Diaz S; Machuca J; Tejada-Gonzalez A; Recacha E; Docobo-Pérez F; Pascual A; Rodríguez-Martínez JM
    J Antimicrob Chemother; 2020 Aug; 75(8):2124-2132. PubMed ID: 32427318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of plasmid-mediated qnr genes among the quinolone-resistant Escherichia coli isolates in Iran.
    Firoozeh F; Zibaei M; Soleimani-Asl Y
    J Infect Dev Ctries; 2014 Jul; 8(7):818-22. PubMed ID: 25022290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.
    Yang J; Luo Y; Cui S; Wang W; Han L
    Microb Drug Resist; 2011 Sep; 17(3):363-7. PubMed ID: 21563956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geographic distribution of fluoroquinolone-resistant Escherichia coli strains in Asia.
    Uchida Y; Mochimaru T; Morokuma Y; Kiyosuke M; Fujise M; Eto F; Harada Y; Kadowaki M; Shimono N; Kang D
    Int J Antimicrob Agents; 2010 Apr; 35(4):387-91. PubMed ID: 20138480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country.
    Christiansen N; Nielsen L; Jakobsen L; Stegger M; Hansen LH; Frimodt-Møller N
    Microb Drug Resist; 2011 Sep; 17(3):395-406. PubMed ID: 21668371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MECHANISMS OF RESISTANCE TO CIPROFLOXACIN AND GENETIC DIVERSITY OF ESCHERICHIA COLI STRAINS ORIGINATING FROM URINE CULTURES PERFORMED FOR ROMANIAN ADULTS.
    Cristea VC; Oprea M; Neacşu G; Gîlcă R; Popa MI; Usein CR
    Roum Arch Microbiol Immunol; 2015; 74(3-4):73-8. PubMed ID: 27328520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of low-level fluoroquinolone resistance genes qnrA1, qnrB19 and qnrS1 on ciprofloxacin treatment of isogenic Escherichia coli strains in a murine urinary tract infection model.
    Jakobsen L; Cattoir V; Jensen KS; Hammerum AM; Nordmann P; Frimodt-Møller N
    J Antimicrob Chemother; 2012 Oct; 67(10):2438-44. PubMed ID: 22685162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.